Pediatric Hodgkin Consortium Trial Updates: Response-based omission of radiotherapy (RT) for the majority of young people with Hodgkin lymphoma (HL) while maintaining excellent outcomes: Five-year results of HOD08 for low-risk (LR) HL and initial results of cHOD17 high-risk (HR) stratum

Angela M. Feraco(Dana-Farber Cancer Institute), Matthew J. Ehrhardt(St. Jude Children's Research Hospital), John T. Lucas(Wake Forest University), Torunn I. Yock(Massachusetts General Hospital), Eric Larsen(University of Massachusetts Chan Medical School), Karen J. Marcus(Harvard University), Stephan D. Voss(Brigham and Women's Hospital), Jamie E. Flerlage(St. Jude Children's Research Hospital), Lianna J. Marks(Stanford Medicine), Yinmei Zhou(St. Jude Children's Research Hospital), Barry L. Shulkin(St. Jude Children's Research Hospital), M. Krasin(St. Jude Children's Research Hospital), Simon Dixon(Beaumont Hospital, Royal Oak), Melissa M. Hudson(Cincinnati Children's Hospital Medical Center), Ying Zheng(Chinese People's Liberation Army), Hesham Magdy Mohammad Elhalawani(Brigham and Women's Hospital), Alison M. Friedmann(Harvard University), Howard J. Weinstein(Harvard University Press), Michael P. Link(Stanford University), Susan M. Hiniker(Stanford University), Sue C. Kaste(St. Jude Children's Research Hospital), P De Alarcon(Illinois College)
Klinische Pädiatrie
December 1, 2025
Cited by 0


Related Papers